Patents by Inventor Ian Zachary

Ian Zachary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arginine Derivatives with NP-I Antagonistic Activity
    Publication number: 20120269864
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: June 11, 2012
    Publication date: October 25, 2012
    Inventors: Haiyan Jia, Ian ZACHARY, Michelle TICKNER, Lili CHENG, Chris CHAPMAN, Katie ELLARD, Basil HARTZOULAKIS, Ashley JARVIS, Rosemary LYNCH, Jamie NALLY, David SELWOOD, Mark STEWART
  • Arginine derivatives with NP-1 antagonistic activity
    Patent number: 8227606
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: July 24, 2012
    Assignee: Ark Therapeutics, Ltd.
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • ARGININE DERIVATIVES WITH NP-I ANTAGONISTIC ACTIVITY
    Publication number: 20120122862
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 17, 2012
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • Arginine derivatives with NP-I antagonistic activity
    Patent number: 8158789
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: April 17, 2012
    Assignee: Ark Therapeutics Group Ltd.
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • Arginine Derivatives with NP-I Antagonistic Activity
    Publication number: 20100022525
    Abstract: The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists.
    Type: Application
    Filed: October 4, 2007
    Publication date: January 28, 2010
    Inventors: Haiyan Jia, Ian Zachary, Michelle Tickner, Lili Cheng, Chris Chapman, Katie Ellard, Basil Hartzoulakis, Ashley Jarvis, Rosemary Lynch, Jamie Nally, David Selwood, Mark Stewart
  • Vegf-induced genes and their therapeutic use
    Publication number: 20070196352
    Abstract: The present invention concerns products for therapeutic use comprising a gene, or product thereof, identified as upregulated by VEGF (vascular endothelial growth factor). Products of the invention can be used, for example, in arterioprotection or promoting angiogenesis.
    Type: Application
    Filed: September 16, 2004
    Publication date: August 23, 2007
    Inventors: Ian Zachary, Dan Liu
  • VEGF peptides and their use for inhibiting angiogenesis
    Patent number: 7223835
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: May 29, 2007
    Assignee: Ark Therapeutics Ltd.
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Vegf peptides and their use
    Publication number: 20060166868
    Abstract: A novel peptide having the amino acid sequence SCKNTDSRCKARQLELNERTCRCDKPRR or a fragment thereof that substantially retains NP-1 antagonist activity, in cyclic form, is proposed for use in therapy.
    Type: Application
    Filed: March 28, 2003
    Publication date: July 27, 2006
    Inventors: David Selwood, Marianne Loehr, Ian Zachary
  • Vegf peptides and their use for inhibiting angiogenesis
    Publication number: 20040054143
    Abstract: A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 18, 2004
    Inventors: David Selwood, Ian Zachary, Haiyan Jia, Marianne Lohr, Dana Davis
  • Growth factor receptors
    Patent number: 5441935
    Abstract: A 75-85 Kd glycopolypeptide, capable of acting as a receptor for polypeptide of the bombesin type, is isolated from the surface of Swiss 3T3 cells. Certain antagonists and antibodies to the glycopolypeptide are described, the antagonists being of quite different structure to bombesin e.g. .differential.D-Pro.sup.2 [-spantide, .differential.D-Phe.sup.5 [-spantide and position 5 variants thereof. The antagonists and antibodies are of interest medically in that they are able to influence cell proliferation that occurs under the influence of the bombesin-like polypeptides.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: August 15, 1995
    Assignee: Imperial Cancer Research Technology Ltd.
    Inventors: Enrique Rozengurt, Ian Zachary, Penella Woll